An Appraisal of Clinically Meaningful Outcomes Guidelines for Oncology Clinical Trials.
Department of Medical Oncology, Kasturba Medical College, Manglaore, India.
Hemanth
H
Kumar
Division of Hematology and Oncology, Columbia University Medical Center, New York, New York.
Tito
T
Fojo
Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Sham
S
Mailankody
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D017277:Drug Approval; D017408:Guidelines as Topic; D006801:Humans; D008495:Medical Oncology; D009369:Neoplasms / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care; D012955:Societies, Medical; D015996:Survival Rate; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents